ask="7.480"
ask_size="200"
average_daily_volume="11700"
bid="N/A"
bid_size="N/A"
book_value="-2.051"
change="-0.003"
change_from_200_day_moving_average="-0.298"
change_from_50_day_moving_average="-0.128"
change_from_52_week_high="-1.513"
change_From_52_week_low="0.157"
change_in_percent="-0.073%"
close="4.087"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.877"
ebitda="-3.99M"
eps_estimate_current_year="-2.950"
eps_estimate_next_quarter="-0.130"
eps_estimate_next_year="-0.480"
ex_dividend_date="N/A"
float_shares="2882000"
high="4.100"
high_52_weeks="5.600"
last_trade_date="3/13/2017"
last_trade_price="4.087"
last_trade_size="3000"
last_trade_time="3:57pm"
low="4.000"
low_52_weeks="3.930"
market_capitalization="39.36M"
moving_average_200_day="4.385"
moving_average_50_day="4.215"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.000"
open="4.100"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-6.800%"
percent_change_from_50_day_moving_average="-3.031%"
percent_change_from_52_week_high="-27.018%"
percent_change_from_52_week_low="+3.995%"
previous_close="4.090"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="2.310"
stock_exchange="NCM"
symbol="AZRX"
volume="28540"
weeks_range_52="3.930 - 5.600"
